Bicycle Therapeutics Financial Health

Short Term Liabilities: BCYC's short term assets ($381.3M) exceed its short term liabilities ($41.6M).

Long Term Liabilities: BCYC's short term assets ($381.3M) exceed its long term liabilities ($86.1M).

Debt Level: BCYC has more cash than its total debt.

Reducing Debt: BCYC's debt to equity ratio has increased from 0% to 10.4% over the past 5 years.

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: BCYC has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: BCYC has sufficient cash runway for 2.4 years if free cash flow continues to reduce at historical rates of 27% each year.

• Healthy companies in the Pharmaceuticals & Biotech industry.